[1]
Dr. Anil Kumar Muthineni, “Efficacy And Safety Of Pirfenidone In Patients With Idiopathic Pulmonary Fibrosis: A Phase Iii Randomized, Double-Blind, Placebo-Controlled Trial”, JRTDD, vol. 5, no. 2, pp. 776–781, Dec. 2022.